Most of the oncology drugs that received the FDA’s accelerated approval from 2011 to 2020 had some kind of FDA postmarketing safety action, according to a research letter. Safety actions included ...
GLP-1 weight-loss drugs are now the focus of a heated legal battle, with a leading drugmaker warning that copycat versions pose a risk to patient safety. "When you go and try to source raw materials ...
Washington, D.C. - The White House Office of National Drug Control Policy (ONDCP) has released a new video on Facebook and Instagram to raise public ...
Add Yahoo as a preferred source to see more of our stories on Google. A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman ...
Add Yahoo as a preferred source to see more of our stories on Google. On the Wednesday, January 28, 2026, episode of The Excerpt podcast: As GLP-1 use surges, lawsuits allege blindness, stomach ...
On the Wednesday, January 28, 2026, episode of The Excerpt podcast: As GLP-1 use surges, lawsuits allege blindness, stomach paralysis and more. USA TODAY Investigative Reporter Austin Fast breaks down ...
A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman vomited for weeks before being diagnosed with a brain dysfunction typically ...
The management of drug safety, a fundamental aspect of public health systems, is currently experiencing a significant shift. As real-world data volumes grow, drug development cycles accelerate, and ...